Literature DB >> 23714311

Diagnosis and management of heparin-induced thrombocytopenia.

Grace M Lee1, Gowthami M Arepally.   

Abstract

Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder caused by antibodies to platelet factor 4/heparin (PF4/H) complexes. It presents with declining platelet counts 5 to 14 days after heparin administration and results in a predisposition to arterial and venous thrombosis. Establishing the diagnosis of HIT can be extremely challenging. It is essential to conduct a thorough clinical evaluation in addition to laboratory testing to confirm the presence of PF4/H antibodies. Multiple clinical algorithms have been developed to aid the clinician in predicting the likelihood of HIT. Once HIT is recognized, an alternative anticoagulant should be initiated to prevent further complications.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23714311      PMCID: PMC3668315          DOI: 10.1016/j.hoc.2013.02.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  123 in total

1.  Arterial embolism occurring during systemic heparin therapy.

Authors:  R E WEISMANN; R W TOBIN
Journal:  AMA Arch Surg       Date:  1958-02

Review 2.  Clinical practice. Heparin-induced thrombocytopenia.

Authors:  Gowthami M Arepally; Thomas L Ortel
Journal:  N Engl J Med       Date:  2006-08-24       Impact factor: 91.245

3.  Laboratory tests for heparin-induced thrombocytopenia: a multicenter study.

Authors:  J M Walenga; W P Jeske; J J Wood; S Ahmad; B E Lewis; M Bakhos
Journal:  Semin Hematol       Date:  1999-01       Impact factor: 3.851

4.  Determination of heparin-induced thrombocytopenia: a rapid flow cytometric assay for direct demonstration of antibody-mediated platelet activation.

Authors:  A Tomer; C Masalunga; T C Abshire
Journal:  Am J Hematol       Date:  1999-05       Impact factor: 10.047

5.  Thrombocytopenia in a surgical ICU.

Authors:  F Stéphan; J Hollande; O Richard; A Cheffi; M Maier-Redelsperger; A Flahault
Journal:  Chest       Date:  1999-05       Impact factor: 9.410

6.  Interleukin-10 promoter microsatellite polymorphisms influence the immune response to heparin and the risk of heparin-induced thrombocytopenia.

Authors:  Claire Pouplard; Pascale Cornillet-Lefebvre; Redha Attaoua; Dorothée Leroux; Carinne Lecocq-Lafon; Jérôme Rollin; Florin Grigorescu; Philippe Nguyen; Yves Gruel
Journal:  Thromb Res       Date:  2012-01-10       Impact factor: 3.944

7.  Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.

Authors:  Bruce E Lewis; Diane E Wallis; Fred Leya; Marcie J Hursting; John G Kelton
Journal:  Arch Intern Med       Date:  2003 Aug 11-25

8.  Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion.

Authors:  Zhihua Xiao; Gian P Visentin; Kannayakanahalli M Dayananda; Sriram Neelamegham
Journal:  Blood       Date:  2008-06-06       Impact factor: 22.113

9.  Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: a survey of North American specialized coagulation laboratories.

Authors:  Elizabeth A Price; Catherine P M Hayward; Karen A Moffat; Jane C Moore; Theodore E Warkentin; James L Zehnder
Journal:  Thromb Haemost       Date:  2007-12       Impact factor: 5.249

10.  Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia.

Authors:  C Pouplard; P Gueret; M Fouassier; C Ternisien; M Trossaert; S Régina; Y Gruel
Journal:  J Thromb Haemost       Date:  2007-03-14       Impact factor: 5.824

View more
  9 in total

1.  Bilateral adrenal haemorrhage: a cause of haemodynamic collapse in heparin-induced thrombocytopaenia.

Authors:  Nasir Saleem; Mahjabeen Khan; Sanober Parveen; Arvind Balavenkatraman
Journal:  BMJ Case Rep       Date:  2016-03-10

2.  Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United States.

Authors:  Ahmed Aljabri; Yvonne Huckleberry; Jason H Karnes; Mahdi Gharaibeh; Hussam I Kutbi; Yuval Raz; Seongseok Yun; Ivo Abraham; Brian Erstad
Journal:  Blood       Date:  2016-10-28       Impact factor: 22.113

3.  Is the incidence trend of heparin-induced thrombocytopenia decreased by the increased use of low-molecular-weight-heparin?

Authors:  Fahad A S Al-Eidan
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-04-20       Impact factor: 2.576

4.  Cerebral Hemorrhage Complicating Heparin-induced Thrombocytopenia after Percutaneous Coronary Intervention: A Clinical Dilemma of Medical Treatment.

Authors:  Xue Qin; Bo Zhang
Journal:  Chin Med J (Engl)       Date:  2015-06-05       Impact factor: 2.628

5.  Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia.

Authors:  José Perdomo; Halina H L Leung; Zohra Ahmadi; Feng Yan; James J H Chong; Freda H Passam; Beng H Chong
Journal:  Nat Commun       Date:  2019-03-21       Impact factor: 14.919

6.  Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report.

Authors:  Wenxi Liu; Chao Zhang; Qiong Bai; Zhongliang Zhang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

7.  Heparin-induced thrombocytopenia and acute colonic pseudo-obstruction after therapeutic anticoagulation in a very elderly patient with hip fracture: a case report.

Authors:  Yijun Liu; Hao Lu; Hailin Xu; Zhongguo Fu; Dianying Zhang; Baoguo Jiang
Journal:  BMC Musculoskelet Disord       Date:  2020-02-07       Impact factor: 2.362

8.  Heparin-Induced Thrombocytopenia in Iranian Cardiac Surgery Patients Using the 4Ts Clinical Scoring System and Laboratory Methods.

Authors:  Minoo Ahmadinejad; Massoumeh Shahbazi; Azita Chegini
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2021-10-01

Review 9.  Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management.

Authors:  Vasileios Patriarcheas; Antonios Pikoulas; Minas Kostis; Andriani Charpidou; Evangelos Dimakakos
Journal:  Cureus       Date:  2020-03-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.